Certain common stock of agile therapeutics, inc. are subject to a lock-up agreement ending on 31-oct-2019.

Certain common stock of agile therapeutics, inc. are subject to a lock-up agreement ending on 31-oct-2019. these common stock will be under lockup for 90 days starting from 2-aug-2019 to 31-oct-2019. details: the officers and directors have agreed that they will not offer, sell, pledge or otherwise dispose of these securities for a period of 90 days following the date of the final prospectus without the prior written consent of oppenheimer & co. inc.
AGRX Ratings Summary
AGRX Quant Ranking